CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The EVOLVE project aims to enhance tumor vaccines by engineering antigen-presenting cells to improve immune responses against cancer. It focuses on overcoming barriers to effective cancer immunotherapy through innovative strategies.
We are witnessing transformative results in the clinical application of both cancer immunotherapies and gene transfertechnologies.
Tumor vaccines are a specific modality of cancer immunotherapy.
Similar to vaccination against pathogens, tumor vaccines are designed to elicit a specific immune response against cancer.
They are based on the administration of inactivated cancer cells or tumor antigens, or the inoculation of antigen-presenting cells (APCs) previously exposed to tumor antigens.
In spi…
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
